The main goal of this study was to analyze the prognosis of dMMR stage III colon cancer and study the prognostic interplay between MMR status, tumor cell PD-L1 expression, and density of CD3+ and CD8+ lymphocytes. This evidence concerns the gene CD8A and colonic neoplasm.